Peak Bio, Inc.

Ignyte Acquisition Corp., trading under the ticker IGNY, is a blank-check company that completed its initial public offering in 2021 with a focus on the healthcare and life sciences sector. Sponsored by Ignyte Sponsor LLC, the SPAC targeted innovative biopharmaceutical businesses and entered into a proposed business combination with Peak Bio, Inc., a clinical-stage oncology company developing antibody-drug conjugate therapies. The February 2023 S-1/A amendment filing with the SEC represents a registration statement update tied to that proposed de-SPAC transaction. For complete filing history, deal timelines, and sponsor data on IGNY and hundreds of other SPACs, sign up for full access at SpacDesk.